Form 8-K - Current report:
SEC Accession No. 0000950170-22-000190
Filing Date
2022-01-10
Accepted
2022-01-10 08:29:10
Documents
13
Period of Report
2022-01-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20220110.htm   iXBRL 8-K 55351
  Complete submission text file 0000950170-22-000190.txt   211714

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srzn-20220110_pre.xml EX-101.PRE 13120
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srzn-20220110_lab.xml EX-101.LAB 17710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srzn-20220110_def.xml EX-101.DEF 13822
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srzn-20220110.xsd EX-101.SCH 3135
7 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20220110_htm.xml XML 6593
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 22519824
SIC: 2836 Biological Products, (No Diagnostic Substances)